(Q36123897)

12 August 2017

Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity (English)

1 reference

12 August 2017

neoplastic stem cells

1 reference

Ahmet Ucar

19

0 references

Sacha Howell

Sacha J Howell

24

0 references

Gillian Farnie

Gillian Farnie

22

0 references

Stefania Catalano

Stefania Catalano

16

0 references

Andrew H. Sims

Andrew H Sims

20

0 references

Robert B. Clarke

Robert B Clarke

25

0 references

Anthony Howell

Anthony Howell

13

0 references

author name string

Bruno M Simões

1

1 reference

12 August 2017

Ciara S O'Brien

2

1 reference

12 August 2017

Rachel Eyre

3

1 reference

12 August 2017

Andreia Silva

4

1 reference

12 August 2017

Ling Yu

5

1 reference

12 August 2017

Aida Sarmiento-Castro

6

1 reference

12 August 2017

Denis G Alférez

7

1 reference

12 August 2017

Kath Spence

8

1 reference

12 August 2017

Angélica Santiago-Gómez

9

1 reference

12 August 2017

Francesca Chemi

10

1 reference

12 August 2017

Ahmet Acar

11

1 reference

12 August 2017

Ashu Gandhi

12

1 reference

12 August 2017

Keith Brennan

14

1 reference

12 August 2017

Lisa Rydén

15

1 reference

12 August 2017

Sebastiano Andó

17

1 reference

12 August 2017

Julia Gee

18

1 reference

12 August 2017

Elisabetta Marangoni

21

1 reference

12 August 2017

Göran Landberg

23

1 reference

12 August 2017

16 September 2015

1 reference

12 August 2017

1 reference

12 August 2017

12

1 reference

12 August 2017

12

1 reference

12 August 2017

1968-1977

1 reference

Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Sox2 promotes tamoxifen resistance in breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Breast cancer: current and future endocrine therapies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

A detailed mammosphere assay protocol for the quantification of breast stem cell activity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Effects of estrogen on the proportion of stem cells in the breast.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Aberrant activation of notch signaling in human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Prospective identification of tumorigenic breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4594158

Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26387946

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26387946

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CELREP.2015.08.050

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26387946

1 reference